Sotagliflozin: a dual sodium-glucose co-transporter-1 and -2 inhibitor for the management of Type 1 and Type 2 diabetes mellitus.
| Image |  |
|---|---|
| Description | scientific article published on 10 April 2018 |
| Author/s |
author: Katherine H Smith Joan Minguet |
| Publication date | July 3, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |